A single case can sometimes change how we think about an entire disease. At the University of Colorado Cancer Center, doctors encountered a patient with a rare and aggressive form of peritoneal mesothelioma that had spread into the abdominal and chest wall.
Instead of moving straight to surgery, the team made a bold choice: Start with immunotherapy. Using a combination of nivolumab and ipilimumab, they set out to see whether the patient’s tumor would respond.
The results were nothing short of remarkable: Scans showed the cancer shrinking dramatically, losing its activity before the surgeons ever stepped in.
A New Approach to Treatment for Peritoneal Mesothelioma
The medical team approached this case with a strategy that combined careful science with bold innovation. They didn’t just follow the usual playbook — they tailored every step of peritoneal mesothelioma treatment to the patient’s tumor biology.
Here’s a closer look at what they did:
- Tested the tumor for PD-L1 – High levels of this protein suggested the tumor might respond well to immunotherapy.
- Started with immunotherapy – Instead of jumping straight to surgery, the patient received nivolumab (Opdivo®) and ipilimumab (Yervoy®) to attack the tumor from the inside out.
- Monitored the tumor’s response – Scans showed it shrinking dramatically and losing metabolic activity, signaling that the therapy was working.
- Performed a targeted surgical resection – With the tumor weakened, surgeons removed the tumor, a portion of the liver, and two ribs to ensure complete removal.
- Checked for remaining cancer cells – Pathology confirmed a complete pathological response, meaning no viable cancer cells were left behind.
- Continued immunotherapy after surgery – The patient stayed on treatment to maintain the response and prevent recurrence.
By combining cutting-edge immunotherapy with precise surgery, the doctors turned a challenging diagnosis into a story of hope and long-term remission.
Use our Free Doctor Match to find local mesothelioma specialists who can administer advanced treatments like immunotherapy.
Still Cancer-Free 3 Years After Treatment
With continued immunotherapy after surgery, the mesothelioma patient was still cancer-free 3 years after treatment, a far longer remission period than many treatments can offer.
The combination of immunotherapy and surgery didn’t just shrink the tumor. Imaging scans showed major changes in the tumor’s appearance and activity, meaning the cancer had already become much less active before surgery.
When the tumor was finally removed, pathology confirmed a complete response, with no viable cancer cells left behind. This outcome highlights how carefully tailored, biology-driven treatment may help produce long-term peritoneal mesothelioma remission, offering hope that other patients might one day experience the same results.
Why This Case Matters for Mesothelioma Patients
This case isn’t just remarkable because of one patient’s experience — it offers a glimpse into what might be possible for others facing peritoneal mesothelioma. Traditionally, treatment options have been limited and survival outcomes grim.
But this approach highlights new avenues for hope:
- Neoadjuvant immunotherapy can work – Starting with immune-based treatment before surgery may shrink tumors and make them easier to remove.
- Tumor biomarkers can guide treatment – High PD-L1 expression may help identify which patients are most likely to respond to immunotherapy.
- Surgery can be more effective after immunotherapy – Weakening the tumor beforehand increases the chances of complete removal.
- Long-term peritoneal mesothelioma remission is possible – The patient in this case has remained cancer-free for 3 years, showing durable benefits.
- A roadmap for future research – This case encourages further studies to see how peritoneal mesothelioma immunotherapy can be integrated into standard care.
In short, this case shows that carefully tailored treatment plans could change the game for patients who previously had few options, offering real hope for longer survival and better quality of life.
Get Help Becoming a Long-Term Survivor
At Mesothelioma Hope, we can help connect you with top resources on nearby doctors, treatment options, clinical trials, support groups, and financial compensation.
“One thing that can make a mesothelioma diagnosis feel more manageable is having a community to support you. Our hope is to foster a space where patients and caregivers can share, connect, and feel less alone. We’re in this together.”
Contact us now for free help fighting this cancer. Our Patient Advocates are here 24/7 to provide you with tips, next steps, and support resources.
